ASH18 Preview: Blood Cancer Immunotherapy Developments November 30, 2018October 31, 2024 Arthur N. Brodsky, PhD
FDA Approves Pembrolizumab Immunotherapy for Advanced Liver Cancer November 9, 2018October 31, 2024 Arthur N. Brodsky, PhD
CICON18 Day 1 Update: T Cells and the Tumor Microenvironment October 1, 2018October 31, 2024 viewstream-admin
CICON18 Day 3 Update: Targeting Tumor Mutations with Vaccine-Based Immunotherapies October 3, 2018October 31, 2024 Arthur N. Brodsky, PhD